A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Lilly bets on Seamless, delving further into genetic medicine for hearing loss
Lilly bets on Seamless, delving further into genetic medicine for hearing loss
Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts
Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts
Halozyme buys a biotech startup; Cytokinetics launches heart drug
Halozyme buys a biotech startup; Cytokinetics launches heart drug
Regenxbio gene therapy trials suspended by FDA over safety worries
Regenxbio gene therapy trials suspended by FDA over safety worries
FDA lifts hold on an Intellia CRISPR drug trial
FDA lifts hold on an Intellia CRISPR drug trial
Roche, trailing in obesity, showcases new data for GLP-1 shot
Roche, trailing in obesity, showcases new data for GLP-1 shot
An immune drug developer raises $50M to finance its eczema drug testing
An immune drug developer raises $50M to finance its eczema drug testing
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says
China’s edge in early-stage drugmaking ‘likely to persist,’ Pitchbook says
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
Sarepta, battling slowing sales, claims Duchenne gene therapy’s impact grows with time
Biotech investor Cormorant secures $150M for another SPAC deal
Biotech investor Cormorant secures $150M for another SPAC deal
Express Scripts considering settlement in FTC insulin price lawsuit
Express Scripts considering settlement in FTC insulin price lawsuit
The formula for biotech success in 2026: Confidence, resilience and funding
The formula for biotech success in 2026: Confidence, resilience and funding
From detection to prevention: How sponsored testing can transform patient outcomes
From detection to prevention: How sponsored testing can transform patient outcomes
The crucial role of raw material selection for success in cell therapy manufacturing
The crucial role of raw material selection for success in cell therapy manufacturing
Sanofi to seek approval of touted eczema drug despite mixed results
Sanofi to seek approval of touted eczema drug despite mixed results
Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal
Novo climbs higher on ‘strong’ Wegovy pill launch; Terns tweaks leukemia drug deal
Congress eyes tackling healthcare consolidation
Congress eyes tackling healthcare consolidation
Investors load Corxel with $287M for a ‘differentiated’ obesity pill
Investors load Corxel with $287M for a ‘differentiated’ obesity pill
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page